EULAR Presentation Showed Upadacitinib Improved Lupus Disease Activity
May 31, 2023
We are pleased to share encouraging news from EULAR, the annual meeting of the European Alliance of...
EULAR
LRA Brings Encouraging News from European Rheumatology Meeting
June 2, 2022
The Lupus Research Alliance (LRA) and its clinical trial arm Lupus Therapeutics congratulate Bristol Myers Squibb (BMS)...
Lupus Research Alliance and Lupus Therapeutics Response to Positive Data from Phase 2 Study on Potential First-in-class Lupus Treatment
The Lupus Research Alliance (LRA) and its clinical affiliate Lupus Therapeutics congratulate Bristol Myers Squibb (BMS) on new positive...
Promising News from Major Medical Meeting, EULAR
Updated June 5, 2020
One of the largest meetings for rheumatologists went virtual this year to enable scientists from around...
LRA Congratulates AstraZeneca on Positive Data on Anifrolumab Presented at Major Medical Meeting
June 3, 2020
The Lupus Research Alliance (LRA) is encouraged by positive data from two studies presented at the European...
Possible Cancer Drug 2DG May Boost Good Immune Cells
June 20, 2019
The investigational drug 2DG, tested as a cancer treatment, shows promise for lupus in new results reported...
Cyclosporine Worked Faster than Mycophenolate Mofetil or Azathioprine for Lupus Nephritis
June 12, 2019
A study presented at EULAR showed that ongoing maintenance therapy with the immunosuppressive drug cyclosporine helped lower...
Results Presented at EULAR Find Investigational Lupus Treatment NKTR-358 Safe
June 13, 2019
New results from a clinical study with healthy volunteers found the investigational compound NKTR-358 safe and well-tolerated,...
New Guidelines for Lupus Treatment From EULAR
April 10, 2019
New recommendations for treating systemic lupus erythematosus were just issued by EULAR – the European League Against...
Baricitinib Shows Positive Results for SLE in Phase 2 Study
June 19, 2018
Once-daily oral baricitinib 4 mg was associated with significant clinical improvements compared with placebo in patients with...